US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...
01 May, 2026, 04.39 PM IST
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
01 May, 2026, 04.15 PM IST
Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
16 Apr, 2026, 07.31 AM IST
Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...
18 Mar, 2026, 12.57 AM IST
Activists sound alarm bells as Gilead seeks rights over HIV drugLenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...
17 Sep, 2024, 11.42 PM IST
Johnson & Johnson tuberculosis drug's final patent hearing set for todayThe latest secondary patent application, if granted, allows J&J to extend the monopoly on the drug used for treatment of drug resistant (DR...
17 Jan, 2023, 11.10 AM IST
- India rejects Abbot lab's patent application for HIV drug
India has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving ...
03 Jan, 2011, 02.46 PM IST
- Pharma cos lose out in patent office-judiciary stand-off
FOR the patent office, the past three years have been like the past three overs of a Twenty20 match.
07 May, 2010, 12.44 AM IST
- Pharma group to oppose patent claims
A group of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some...
29 Apr, 2010, 02.17 AM IST
- Indian drugmakers gear up to challenge frivolous MNC patents
Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...
11 Apr, 2010, 11.48 AM IST
- New Delhi rejects American firm's plea to patent Hepatitis B drug
The Delhi Patent Office has rejected American company Gilead Sciences’ plea to patent its Hepatitis B drug adefovir dipivoxil sold under th...
01 May, 2009, 07.47 PM IST
- Now, generic drug cos pop patent pill
Generic drug companies too have joined the rush to seek patents for drugs in India.
02 Jun, 2008, 12.16 AM IST
- Most Indian drug majors too in line for patent protection
Out of the 8,000 drug patent applications in India filed between 1995 and 2004, about 40% are from Indian pharma companies.
14 Dec, 2007, 12.46 AM IST
- GSK drops claims on two AIDS medicines
In a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...
07 Dec, 2007, 01.11 AM IST
- Wockhardt moves HC for patent law
The case will reopen the debate on value of incremental innovation as cos seek clarity on patent law.
04 Apr, 2007, 02.00 AM IST
- It’s patent vs patient in AIDS fight
The battle lines between Western pharmaceutical transnationals and NGOs and patients’ associations are now drawn sharper than ever before. ...
15 Feb, 2007, 01.50 AM IST
- Local pharma strikes first in patent war
Global innovator pharma companies and domestic generic players are sparring with each other in the wake of India’s new product patent regim...
23 Oct, 2006, 03.34 AM IST